Li X - Search Results

1

Phase 2 trial of rituximab and bortezomib in patients with relapsed or refractory mantle cell and follicular lymphoma.

Baiocchi RA, Alinari L, Lustberg ME, Lin TS, Porcu P, Li X, Johnston JS, Byrd JC, Blum KA. Baiocchi RA, et al. Among authors: li x. Cancer. 2011 Jun 1;117(11):2442-51. doi: 10.1002/cncr.25792. Epub 2010 Dec 14. Cancer. 2011. PMID: 24048792 Free PMC article. Clinical Trial.

2

Fixed-dose-rate gemcitabine in combination with oxaliplatin in patients with metastatic pancreatic cancer refractory to standard-dose-rate gemcitabine: a single-institute study.

Fortune BE, Li X, Kosuri KV, Weatherby LM, Thomas JP, Bekaii-Saab TS. Fortune BE, et al. Among authors: li x. Oncology. 2009;76(5):333-7. doi: 10.1159/000209962. Epub 2009 Mar 23. Oncology. 2009. PMID: 19307739 Clinical Trial.

3

Phase I trial of non-cytotoxic suramin as a modulator of docetaxel and gemcitabine therapy in previously treated patients with non-small cell lung cancer.

Lam ET, Au JL, Otterson GA, Guillaume Wientjes M, Chen L, Shen T, Wei Y, Li X, Bekaii-Saab T, Murgo AJ, Jensen RR, Grever M, Villalona-Calero MA. Lam ET, et al. Among authors: li x. Cancer Chemother Pharmacol. 2010 Nov;66(6):1019-29. doi: 10.1007/s00280-010-1252-x. Epub 2010 Jan 28. Cancer Chemother Pharmacol. 2010. PMID: 20107799 Free PMC article. Clinical Trial.

4

A phase I study of the biomodulation of capecitabine by docetaxel and gemcitabine (mGTX) in previously untreated patients with metastatic adenocarcinoma of the pancreas.

Hill ME, Li X, Kim S, Campbell A, Culler K, Bloomston M, Zalupski M, Hejna G, Bekaii-Saab T. Hill ME, et al. Among authors: li x. Cancer Chemother Pharmacol. 2011 Mar;67(3):511-7. doi: 10.1007/s00280-010-1348-3. Epub 2010 May 12. Cancer Chemother Pharmacol. 2011. PMID: 20461379 Clinical Trial.

5

Flavopiridol pharmacogenetics: clinical and functional evidence for the role of SLCO1B1/OATP1B1 in flavopiridol disposition.

Ni W, Ji J, Dai Z, Papp A, Johnson AJ, Ahn S, Farley KL, Lin TS, Dalton JT, Li X, Jarjoura D, Byrd JC, Sadee W, Grever MR, Phelps MA. Ni W, et al. Among authors: li x. PLoS One. 2010 Nov 1;5(11):e13792. doi: 10.1371/journal.pone.0013792. PLoS One. 2010. PMID: 21072184 Free PMC article. Clinical Trial.

6

Phase II trial of exemestane in combination with fulvestrant in postmenopausal women with advanced, hormone-responsive breast cancer.

Mrózek E, Layman R, Ramaswamy B, Schaaf L, Li X, Ottman S, Shapiro CL. Mrózek E, et al. Among authors: li x. Clin Breast Cancer. 2012 Apr;12(2):151-6. doi: 10.1016/j.clbc.2012.01.003. Clin Breast Cancer. 2012. PMID: 22444722 Free PMC article. Clinical Trial.

7

Influence of KRAS mutation status in metachronous and synchronous metastatic colorectal adenocarcinoma.

Rose JS, Serna DS, Martin LK, Li X, Weatherby LM, Abdel-Misih S, Zhao W, Bekaii-Saab T. Rose JS, et al. Among authors: li x. Cancer. 2012 Dec 15;118(24):6243-52. doi: 10.1002/cncr.27666. Epub 2012 Jun 6. Cancer. 2012. PMID: 22674181 Free PMC article.

8

VEGF remains an interesting target in advanced pancreas cancer (APCA): results of a multi-institutional phase II study of bevacizumab, gemcitabine, and infusional 5-fluorouracil in patients with APCA.

Martin LK, Li X, Kleiber B, Ellison EC, Bloomston M, Zalupski M, Bekaii-Saab TS. Martin LK, et al. Among authors: li x. Ann Oncol. 2012 Nov;23(11):2812-2820. doi: 10.1093/annonc/mds134. Epub 2012 Jul 5. Ann Oncol. 2012. PMID: 22767582 Free PMC article. Clinical Trial.

9

Carbohydrate antigen 19-9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine-containing chemotherapy: a pooled analysis of 6 prospective trials.

Bauer TM, El-Rayes BF, Li X, Hammad N, Philip PA, Shields AF, Zalupski MM, Bekaii-Saab T. Bauer TM, et al. Among authors: li x. Cancer. 2013 Jan 15;119(2):285-92. doi: 10.1002/cncr.27734. Epub 2012 Jul 11. Cancer. 2013. PMID: 22786786 Free PMC article.

10

Hedgehog signaling is a novel therapeutic target in tamoxifen-resistant breast cancer aberrantly activated by PI3K/AKT pathway.

Ramaswamy B, Lu Y, Teng KY, Nuovo G, Li X, Shapiro CL, Majumder S. Ramaswamy B, et al. Among authors: li x. Cancer Res. 2012 Oct 1;72(19):5048-59. doi: 10.1158/0008-5472.CAN-12-1248. Epub 2012 Aug 8. Cancer Res. 2012. PMID: 22875023 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180,827 results

Search Page

Filters